127 related articles for article (PubMed ID: 8093658)
21. The use of docetaxel (Taxotere) in patients with advanced non-small cell lung cancer previously treated with platinum-containing chemotherapy regimens.
Fossella FV; Rigas J
Semin Oncol; 1999 Jun; 26(3 Suppl 11):9-12. PubMed ID: 10458204
[TBL] [Abstract][Full Text] [Related]
22. Action of the vinca alkaloids vincristine, vinblastine, and desacetyl vinblastine amide on microtubules in vitro.
Himes RH; Kersey RN; Heller-Bettinger I; Samson FE
Cancer Res; 1976 Oct; 36(10):3798-802. PubMed ID: 954003
[TBL] [Abstract][Full Text] [Related]
23. [Taxotere: from yew's needles to clinical practice].
Lavelle F; Gueritte-Voegelein F; Guenard D
Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
[TBL] [Abstract][Full Text] [Related]
24. Studies with RP 56976 (taxotere): a semisynthetic analogue of taxol.
Ringel I; Horwitz SB
J Natl Cancer Inst; 1991 Feb; 83(4):288-91. PubMed ID: 1671606
[TBL] [Abstract][Full Text] [Related]
25. In vitro evaluation of antimicrotubule agents in human small-cell lung cancer cell lines.
Ikubo S; Takigawa N; Ueoka H; Kiura K; Tabata M; Shibayama T; Chikamori M; Aoe K; Matsushita A; Harada M
Anticancer Res; 1999; 19(5B):3985-8. PubMed ID: 10628341
[TBL] [Abstract][Full Text] [Related]
26. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
Kubota K
Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
[TBL] [Abstract][Full Text] [Related]
27. Taxol: the first of the taxanes, an important new class of antitumor agents.
Rowinsky EK; Onetto N; Canetta RM; Arbuck SG
Semin Oncol; 1992 Dec; 19(6):646-62. PubMed ID: 1361079
[TBL] [Abstract][Full Text] [Related]
28. The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review.
Wang LG; Liu XM; Kreis W; Budman DR
Cancer Chemother Pharmacol; 1999; 44(5):355-61. PubMed ID: 10501907
[TBL] [Abstract][Full Text] [Related]
29. Docetaxel combination produces 2-year survival advantage in NSCLC patients.
Oncology (Williston Park); 2001 Dec; 15(12):1559, 1564. PubMed ID: 11780700
[No Abstract] [Full Text] [Related]
30. In situ analysis of the action of Navelbine on various types of microtubules using immunofluorescence.
Binet S; Fellous A; Lataste H; Krikorian A; Couzinier JP; Meininger V
Semin Oncol; 1989 Apr; 16(2 Suppl 4):5-8. PubMed ID: 2652320
[TBL] [Abstract][Full Text] [Related]
31. Docetaxel: a review of its pharmacology and clinical activity.
Trudeau ME
Can J Oncol; 1996 Jun; 6(1):443-57. PubMed ID: 8853517
[TBL] [Abstract][Full Text] [Related]
32. Tubulin and microtubules as targets for anticancer drugs.
Hadfield JA; Ducki S; Hirst N; McGown AT
Prog Cell Cycle Res; 2003; 5():309-25. PubMed ID: 14593726
[TBL] [Abstract][Full Text] [Related]
33. Eleutherobin, a novel cytotoxic agent that induces tubulin polymerization, is similar to paclitaxel (Taxol).
Long BH; Carboni JM; Wasserman AJ; Cornell LA; Casazza AM; Jensen PR; Lindel T; Fenical W; Fairchild CR
Cancer Res; 1998 Mar; 58(6):1111-5. PubMed ID: 9515790
[TBL] [Abstract][Full Text] [Related]
34. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue.
Bissery MC; Guénard D; Guéritte-Voegelein F; Lavelle F
Cancer Res; 1991 Sep; 51(18):4845-52. PubMed ID: 1680023
[TBL] [Abstract][Full Text] [Related]
35. Effect of microtubule disruption on cell adhesion and spreading.
Kadi A; Pichard V; Lehmann M; Briand C; Braguer D; Marvaldi J; Rognoni JB; Luis J
Biochem Biophys Res Commun; 1998 May; 246(3):690-5. PubMed ID: 9618274
[TBL] [Abstract][Full Text] [Related]
36. Combination docetaxel/vinorelbine for metastatic breast cancer and non-small-cell lung cancer.
Aapro MS
Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):46-9. PubMed ID: 9364543
[TBL] [Abstract][Full Text] [Related]
37. Discovery of Inhibitors of Membrane Traffic from a Panel of Clinically Effective Anticancer Drugs.
Kamata H; Sadahiro S; Yamori T
Biol Pharm Bull; 2019 May; 42(5):814-818. PubMed ID: 30787205
[TBL] [Abstract][Full Text] [Related]
38. Bcl2 is the guardian of microtubule integrity.
Haldar S; Basu A; Croce CM
Cancer Res; 1997 Jan; 57(2):229-33. PubMed ID: 9000560
[TBL] [Abstract][Full Text] [Related]
39. Vinorelbine. A review of its antitumour activity in lung cancer.
Sørensen JB
Drugs; 1992; 44 Suppl 4():60-5; discussion 66-9. PubMed ID: 1283851
[TBL] [Abstract][Full Text] [Related]
40. [Navelbine. Current and perspective aspects. International congress of Biarritz (November 1989)].
Armand JP
Bull Cancer; 1990; 77(8):841-5. PubMed ID: 2169931
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
